Alimera Sciences
Alimera Sciences, Inc. (NASDAQ: ALIM) (“Alimera”), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Our lead product is ILUVIEN, now approved for marketing in the U...
Org chart
Discover similar companies
TRICIDA
Post IPO Equity • South San Francisco, United States
Emmaus Medical
Post IPO Equity • Torrance, United States
Catalyst Pharmaceuticals
Post IPO Equity • Coral Gables, United States
Spectrum Pharmaceuticals
Post IPO Equity • Henderson, United States
DURECT
Post IPO Equity • Cupertino, United States
Insys Therapeutics
Post IPO Equity • Phoenix, United States
Zosano Pharma
Post IPO Debt • Fremont, United States
Regulus Therapeutics
Post IPO Equity • San Diego, United States
Trevena
Post IPO Equity • King of Prussia, United States
Senti Biosciences
Post IPO Equity • South San Francisco, United States
Fulcrum Therapeutics
Post IPO Equity • Cambridge, United States
VistaGen Therapeutics
Post IPO Equity • South San Francisco, United States
helps you hire
great candidates
It’s free to use - try it out today.